| Theme | Designated intractable kidney diseases：The control in non-dialysis CKD and renal replacement therapy | |
|---|---|---|
| Title | Intractable kidney disease in chronic kidney disease (CKD) and renal replacement treatment | |
| Publish Date | 2016/04 | |
| Author | Shinichi Nishi | Division of Nephrology and Kidney Center, Kobe University Graduate School of Medicine |
| [ Summary ] | The number of intractable diseases as designated by the Japanese Health, Labour and Welfare Ministry has increased. These conditions include new renal diseases. Patients with intractable renal diseases often progress to end stage kidney disease, moderated control is necessary through the stages of non-dialysis CKD, as well as at the initiation of renal replacement treatment. Many questions are involved with the consecutive steps of one unresolved control. Matter is how to prevent the reactivation of intractable renal diseases after the start of renal replacement therapy. There is only limited evidence as to whether new therapeutic agents for intractable renal diseases are effective or not after the initiation of renal replacement therapy. Healthcare professionals engaging in renal replacement therapy must deal with these questions concerning intractable renal diseases in a careful manner. | |